Targeting tumour behaviour may lead to new liver cancer drugs

Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumour behaviour. The agents target multiple genes associated with that behaviour at one time...

Read the whole article on

More from